214 related articles for article (PubMed ID: 11303778)
1. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
Steingart RA; Solomon B; Brenneman DE; Fridkin M; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):137-45. PubMed ID: 11303778
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
[TBL] [Abstract][Full Text] [Related]
3. VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.
Sigalov E; Fridkin M; Brenneman DE; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):147-54. PubMed ID: 11303779
[TBL] [Abstract][Full Text] [Related]
4. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
Busciglio J; Pelsman A; Helguera P; Ashur-Fabian O; Pinhasov A; Brenneman DE; Gozes I
Curr Pharm Des; 2007; 13(11):1091-8. PubMed ID: 17430172
[TBL] [Abstract][Full Text] [Related]
5. From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.
Gozes I; Divinsky I; Pilzer I; Fridkin M; Brenneman DE; Spier AD
J Mol Neurosci; 2003; 20(3):315-22. PubMed ID: 14501014
[TBL] [Abstract][Full Text] [Related]
6. CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor.
White DM; Walker S; Brenneman DE; Gozes I
Brain Res; 2000 Jun; 868(1):31-8. PubMed ID: 10841885
[TBL] [Abstract][Full Text] [Related]
7. A new concept in the pharmacology of neuroprotection.
Gozes I; Brenneman DE
J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
9. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE
Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470
[TBL] [Abstract][Full Text] [Related]
10. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.
Gozes I; Giladi E; Pinhasov A; Bardea A; Brenneman DE
J Pharmacol Exp Ther; 2000 Jun; 293(3):1091-8. PubMed ID: 10869414
[TBL] [Abstract][Full Text] [Related]
11. [Neuroprotective role of PACAP, VIP, and PHI in the central nervous system].
Sokołowska P; Dejda A; Nowak JZ
Postepy Hig Med Dosw (Online); 2004; 58():416-27. PubMed ID: 15577749
[TBL] [Abstract][Full Text] [Related]
12. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
Brenneman DE; Glazner G; Hill JM; Hauser J; Davidson A; Gozes I
Ann N Y Acad Sci; 1998 Dec; 865():207-12. PubMed ID: 9928014
[TBL] [Abstract][Full Text] [Related]
13. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
Brenneman DE; Hauser J; Neale E; Rubinraut S; Fridkin M; Davidson A; Gozes I
J Pharmacol Exp Ther; 1998 May; 285(2):619-27. PubMed ID: 9580606
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
[TBL] [Abstract][Full Text] [Related]
15. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.
Gozes I; Perl O; Giladi E; Davidson A; Ashur-Fabian O; Rubinraut S; Fridkin M
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4143-8. PubMed ID: 10097177
[TBL] [Abstract][Full Text] [Related]
16. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.
Zamostiano R; Pinhasov A; Bassan M; Perl O; Steingart RA; Atlas R; Brenneman DE; Gozes I
Neurosci Lett; 1999 Apr; 264(1-3):9-12. PubMed ID: 10320001
[TBL] [Abstract][Full Text] [Related]
17. Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.
Smith-Swintosky VL; Gozes I; Brenneman DE; D'Andrea MR; Plata-Salaman CR
J Mol Neurosci; 2005; 25(3):225-38. PubMed ID: 15800376
[TBL] [Abstract][Full Text] [Related]
18. The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro.
Lagrèze WA; Pielen A; Steingart R; Schlunck G; Hofmann HD; Gozes I; Kirsch M
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):933-8. PubMed ID: 15728550
[TBL] [Abstract][Full Text] [Related]
19. SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival.
Ashur-Fabian O; Perl O; Lilling G; Fridkin M; Gozes I
Peptides; 1999; 20(5):629-33. PubMed ID: 10465516
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effects of Theaflavins Against Oxidative Stress-Induced Apoptosis in PC12 Cells.
Zhang J; Cai S; Li J; Xiong L; Tian L; Liu J; Huang J; Liu Z
Neurochem Res; 2016 Dec; 41(12):3364-3372. PubMed ID: 27686660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
